Eton Pharmaceuticals, Inc.
ETONUnited States
41 filed reports · 381 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
41 reports · Sep 2018 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 15 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 24 | 2,927 | Sep 2018 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 8 | 2,323 | Dec 2018 to Dec 2025 |
| Current · 8-KSEC EDGAR | 8 | 15 | Dec 2020 to Jun 2026 |
| Annual · 10-K/ASEC EDGAR | 1 | 1 | Dec 2023 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 13, 2026 | 2 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 13, 2026 | 292 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 14, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 14, 2026 | 190 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 19, 2026 | 669 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Mar 19, 2026 | 1 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 2 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 202 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 130 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 4 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 13, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 13, 2025 | 123 | Open |
Financial data
381 concepts · 5,266 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial374 concepts · 5,080 facts · Sep 2017 to Jun 2026
- Cash and cash equivalents at carrying value44 · Sep 2017 to Jun 2026
- Stockholders equity (US GAAP)44 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations43 · Dec 2017 to Jun 2026
- General and administrative expense (US GAAP)43 · Sep 2017 to Jun 2026
- Net income loss43 · Sep 2017 to Jun 2026
- Operating expenses (US GAAP)43 · Sep 2017 to Jun 2026
- Operating income loss43 · Sep 2017 to Jun 2026
- Research and development expense43 · Sep 2017 to Jun 2026
- Accounts payable current42 · Dec 2017 to Jun 2026
- Assets42 · Dec 2017 to Jun 2026
- Assets current42 · Dec 2017 to Jun 2026
- Common stock par or stated value per share42 · Dec 2017 to Jun 2026
- Common stock shares authorized42 · Dec 2017 to Jun 2026
- Common stock shares issued42 · Dec 2017 to Jun 2026
- Common stock shares outstanding42 · Dec 2017 to Jun 2026
- Common stock value42 · Dec 2017 to Jun 2026
- Depreciation and amortization42 · Mar 2018 to Jun 2026
- Increase decrease in accounts payable42 · Mar 2018 to Jun 2026
- Increase decrease in accrued liabilities42 · Mar 2018 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets42 · Mar 2018 to Jun 2026
- Liabilities42 · Dec 2017 to Jun 2026
- Liabilities and stockholders equity42 · Dec 2017 to Jun 2026
- Liabilities current42 · Dec 2017 to Jun 2026
- Net cash provided by used in operating activities42 · Mar 2018 to Jun 2026
Product5 concepts · 171 facts · Mar 2019 to Jun 2026
- Revenue88 · Mar 2019 to Jun 2026
- Cost of goods and services sold (US GAAP)71 · Mar 2020 to Jun 2026
- Licensing Revenue10 · Dec 2019 to Jun 2022
- Capital Expenditures1 · Oct 2023
- Deferred revenue revenue recognized11 · Dec 2022
Guidance2 concepts · 15 facts · Mar 2021 to Aug 2026
- Gross Margin Guidance8 · May 2025 to Aug 2026
- Revenue Guidance7 · Mar 2021 to Aug 2026
Segments
171 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service6 members · 171 facts
- Product Sales And Royalties66 · Dec 2020 to Mar 2026
- License46 · Dec 2021 to Jun 2026
- Licensing Revenue27 · Mar 2019 to Dec 2022
- Product27 · Dec 2019 to Jun 2026
- Royalty4 · Mar 2021 to Mar 2022
- Capsules1 · Oct 2023
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.